Gene · 2852
Papers4,367
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 4,367
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Asparagine, colorectal cancer, and the role of sex, genes, microbes, and diet: A narrative review. | Front Mol Biosci | 2022 | 36090030 | PubTator, text mining | PubMed |
| Dibutyl phthalate promotes angiogenesis in EA.hy926 cells through estrogen receptor-dependent activation of ERK1/2, PI3K-Akt, and NO signaling pathways. | Chem Biol Interact | 2022 | 36089060 | PubTator, text mining | PubMed |
| Membrane estrogen receptor ERα activation improves tau clearance via autophagy induction in a tauopathy cell model. | Brain Res | 2022 | 36088959 | PubTator, text mining | PubMed |
| An Overview of Essential Microelements and Common Metallic Nanoparticles and Their Effects on Male Fertility. | Int J Environ Res Public Health | 2022 | 36078782 | PubTator, text mining | PubMed |
| Expression of CSF1, AR, and SRD5A2 during Postnatal Development of the Boar Reproductive Tract. | Animals (Basel) | 2022 | 36077888 | PubTator, text mining | PubMed |
| Identification of Gender- and Subtype-Specific Gene Expression Associated with Patient Survival in Low-Grade and Anaplastic Glioma in Connection with Steroid Signaling. | Cancers (Basel) | 2022 | 36077653 | PubTator, text mining | PubMed |
| Is Melanoma Progression Affected by Thyroid Diseases? | Int J Mol Sci | 2022 | 36077430 | PubTator, text mining | PubMed |
| Chrysin-Induced G Protein-Coupled Estrogen Receptor Activation Suppresses Pancreatic Cancer. | Int J Mol Sci | 2022 | 36077069 | PubTator, text mining | PubMed |
| CYP1B1 Augments the Mesenchymal, Claudin-Low, and Chemoresistant Phenotypes of Triple-Negative Breast Cancer Cells. | Int J Mol Sci | 2022 | 36077068 | PubTator, text mining | PubMed |
| Nonylphenol Promoted Epithelial-Mesenchymal Transition in Colorectal Cancer Cells by Upregulating the Expression of Regulator of Cell Cycle. | Chem Res Toxicol | 2022 | 36074022 | PubTator, text mining | PubMed |
| Endocrine therapy resistance: what we know and future directions. | Explor Target Antitumor Ther | 2022 | 36071983 | PubTator, text mining | PubMed |
| PyBioPAX: biological pathway exchange in Python. | J Open Source Softw | 2022 | 36071952 | PubTator, text mining | PubMed |
| Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist. | Pharmacol Res Perspect | 2022 | 36065843 | PubTator, text mining | PubMed |
| Role of estrogen receptors in health and disease. | Front Endocrinol (Lausanne) | 2022 | 36060947 | PubTator, text mining | PubMed |
| Relationship between metabolic reprogramming and drug resistance in breast cancer. | Front Oncol | 2022 | 36059650 | PubTator, text mining | PubMed |
| Steviol glycosides affect functional properties and macromolecular expression of breast cancer cells. | IUBMB Life | 2022 | 36054915 | PubTator, text mining | PubMed |
| Intersections of endocrine pathways and the epithelial mesenchymal transition in endometrial cancer. | Front Oncol | 2022 | 36052252 | PubTator, text mining | PubMed |
| CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer. | Front Immunol | 2022 | 36052076 | PubTator, text mining | PubMed |
| Expression and Role of TRIM2 in Human Diseases. | Biomed Res Int | 2022 | 36051486 | PubTator, text mining | PubMed |
| High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes. | NPJ Breast Cancer | 2022 | 36042244 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2852/papers?page=51